have i seen i am legend?

heres a hint. this is the movie that netflix is sending to us today. my wife controls the queue, and i have less priority than my children.

http://cdn-3.nflximg.com/en_us/boxshots/gsd/70120143.jpg

basically, if its not romcom, and if it doesnt have sing-a-long songs in it, i have not seen it. unless it was produced before 2002.

Obviously I would defer to Monte on any specifics on this topic. I have nothing resembling experience in the biomedical field.

I'll leave the identifying of cancer cells to the pros; but when you do identify them; my nanobots will kick there ass. I guaaaaaraaaantee!

Cancer took a grandfather, grandmother, and uncle from me. My father was diagnosed in December with kidney cancer and my 16-year-old cousin was hit with the bad news THIS MORNING about a rare type of cancer of the stomach/intestines.

Monte......kick cancers ass please!!!

awww Thrax, sorry to hear about the bad news

I agree with deadcode that more funding doesn't necessarily mean faster research.

To put it simple: if the current estimated time for a breakthrough would be 10 years, giving 10 times as much funding won't make the discovery happen in 1 year. In some cases, the tenfold increase in budget would knock off 7 years, in some other cases 1 or 2 years faster would be a great result. It depends what the limiting factor is, sometimes it is just time or one lucky idea.

Only I have worked for about 5 years in fundamental research before and I am sure there still is huge room for improvement in funding (and related to that: a big potential to speed some medical breakthroughs up by many years).

So I do agree overfunding will only spill money but I think some research branches with huge benefits for humanity are currently largely underfunded too.

BTW, here is the peer reviewed article that deals with this research.

http://www.nature.com/bjc/journal/v99/n7/full/6604554a.html

tl;dr - it only works with certain types of cancer (breast, prostate, small-cell lung, endometrial) when used in small doses in the early stages of tumor development and in conjunction with other cancer treatments like chemo.

i could go into more depth on the mechanisms and stuff, but its all outlined in the paper.

but just to echo monte again--- they are just now starting in vivo testing on humans, so curb your enthusiasm.

also, one of you guys should definitely hire me as a lab tech

chas the types

(breast, prostate, small-cell lung, endometrial)
are between 38% and 56% of all cancer, pretty damn huge!
http://www.cancer.gov/cancertopics/types/commoncancers

well, anyways, still not a good article the one that started the thread :P

man I am starting to miss lab work